Welch Allyn
Clinical trials sponsored by Welch Allyn, explained in plain language.
A medical device company producing diagnostic and patient monitoring equipment, owned by Hillrom.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
Tiny trial of infant blood pressure cuff ends early
Knowledge-focused Stopped earlyThis study tested a new blood pressure device called ModPG3 on 7 newborns and infants to see if it meets international accuracy standards. The device uses two methods to measure blood pressure during cuff inflation and deflation. The trial was terminated early, so results are lim…
Sponsor: Welch Allyn • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Blood pressure algorithm study ends early – no major breakthrough
Knowledge-focused Stopped earlyThis study tested two new algorithms (SureBP and StepBP) in a blood pressure device to see if they measure blood pressure accurately in adults and children ages 3 and up. The goal was to check if the device meets international accuracy standards. The study was terminated early, s…
Sponsor: Welch Allyn • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC